The relationship between tTG IgA (tissue transglutaminase IgA, a marker for celiac disease) and menopause is not well established in the scientific literature. The provided context contains no direct evidence linking these two topics. Generally, tTG IgA is used for celiac disease screening, an autoimmune condition triggered by gluten. Menopause involves hormonal changes that can affect immune function, and some observational data suggest autoimmune diseases may emerge or fluctuate during this period. However, a specific, causal connection between tTG IgA levels and menopause has not been demonstrated in robust human studies. The evidence is therefore unclear. Without further research, it would be speculative to claim a direct relationship. Clinically, tTG IgA should remain primarily a tool for celiac disease diagnosis, regardless of menopausal status. Elevated levels warrant gastroenterological evaluation.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-11d4f289a77d0696ea8ed791